Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-20
1997-01-28
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514553, 514597, A61K 3144
Patent
active
055978304
ABSTRACT:
Suramin in combination with a vinca alkaloid or estramustine is synergistic for treating cancer.
REFERENCES:
patent: 5158940 (1992-10-01), LaRocca et al.
Carter et al., Chemotherapy of Cancer, 2nd Ed, 1981, Johy Wiley & Sons, N.Y., N.Y., pp. 82-85.
PCT International Search Report, PCT/US 95/14008.
Proceedings of the American Association for Cancer Research, vol. 35, 1994, Rago et al., p. 329, abstract 1956.
Molecular Pharmacology, vol. 33, No. 4, 1988, Zamora et al., pp. 454-462.
Studies of Suramin (Antrypol: Bayer 205), vol. 40, 1946, Dewey et al., pp. 119-124.
Journal of Clinical Oncology, vol. 7, No. 4, 1989, Stein et al., pp. 499-508.
Journal of the National Cancer Institute, vol. 86, No. 20, 1994, Chou et al., pp. 1517-1524.
Synergism and Antagonism in Chemotherapy, Chapter 6, 1991, Chou et al., pp. 223-241.
Journal of the National Cancer Institute, vol. 82, No. 14, 1990, Fruehauf et al., pp. 1206-1209.
Klohs Wayne D.
Kowal Charles D.
Ashbrook Charles W.
Goldberg Jerome D.
Warner-Lambert & Company
LandOfFree
Combination chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination chemotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941698